Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131703) titled 'A Prospective, Multicenter, Single-Arm Objective Performance Criterion Clinical Trial to Evaluate the Efficacy and Safety of the Transcatheter Mitral Valve Repair System' on Sept. 6.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University

Condition: Mitral valve regurgitation

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2022-02-23

Target Sample Size: Experimental Group:118;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341803

Published by HT Digital ...